drugset / Trial / NCT04842435
Clinical Study in the Treatment of Patients With Moderate Course of COVID-19
RandomizedParallel-groupDouble-blindTreatment
Summary
Study of safety, efficacy and pharmacokinetics, dose selection
Timeline
- Start
- 2021-04-12
- Primary completion
- 2021-09-30
- Completion
- 2021-10-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | COVID-globulin | Protein / enzyme biologic | 1 unknown | Intravenous |
| Subject | COVID-globulin | Protein / enzyme biologic | 2 unknown | Intravenous |
| Subject | COVID-globulin | Protein / enzyme biologic | 4 unknown | Intravenous |